drugset / Trial / NCT02716610
Dose-Response and Variability of Inhaled Insulin in Type 2 Diabetes
RandomizedCrossoverOpen-label
Summary
Pharmacokinetic (PK) and Pharmacodynamic (PD) dose-response investigation of Dance-501 inhaled human insulin
Timeline
- Start
- 2013-10
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INH | Unknown | 69 iu | Inhaled |
| Subject | INH | Unknown | 139 iu | Inhaled |
| Subject | INH | Unknown | 208 iu | Inhaled |
| Comparator | Insulin Lispro | Protein / enzyme biologic | 18 iu | Subcutaneous |